An interventional study of Link work intervention in Mental Health, Oral Health Care and Psychosis, sponsored by Lancashire and South Cumbria NHS Foundation Trust. Recruiting at 5 sites in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-27.
Sponsored by Lancashire and South Cumbria NHS Foundation Trust · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 75 studies in Psychotic Disorders with a site in United Kingdom — 19 open to participants now, 22 under way, 4 of them phase 3. Psychotic Disorders · United Kingdom.
Among the 75 studies in Psychotic Disorders with a site in United Kingdom, this one is the 6th largest by planned enrollment of the 60 interventional ones that give a count, is one of 7 that started in 2026, is one of 37 with no phase, reaches primary completion later than 18 of the 21 other live ones, and was the 72nd registered.
1,593 studies on the registry are indexed under Psychotic Disorders; 283 are open to participants now.
Browse Psychotic Disorders studies →19 of the 75 studies in Psychotic Disorders with a site in United Kingdom are open now. Recruiting first, the newest first:
University of Oxford · Sites in United Kingdom, Austria, Germany and 6 more countries
Ages 16–40
Bristol-Myers Squibb · Sites in United Kingdom, United States, Australia and 2 more countries
Ages 55–90
University of Manchester · Sites in United Kingdom
Ages 16+
University of Nottingham · Sites in United Kingdom
Ages 18–55 · Healthy volunteers
King's College London · Sites in United Kingdom
Ages 18–65 · Healthy volunteers
A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →
Of the 204 Psychotic Disorders studies recruiting now, 53 (26%) set no upper age limit and 142 (70%) stop at 75 or younger; 50 take children under 18; 41 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
75 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 4 · Phase 2 4 · Phase 3 12 · Phase 4 5
First in 2002; this study’s year is marked. 7 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 480 is above the median of 65 across 1,326 interventional studies indexed under Psychotic Disorders.
Median enrollment 59 across the 60 interventional studies, 300 across the 15 observational. Of the 45 that completed or were terminated, 9 (20%) have results posted.
This tab as a report to print or save as PDF → With an account.
12 of 75 have an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with Lancashire and South Cumbria NHS Foundation Trust as lead sponsor.
Lancashire and South Cumbria NHS Foundation Trust has 1 study filed under Psychotic Disorders — fewer than ten, so there is no comparison to draw.
6 of the studies in Psychotic Disorders with a site in United Kingdom that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07252206University of ManchesterA Case Series of Culturally-adapted CBTp for Black People in the UK | 2026-12 |
| NCT07398365University of EdinburghMedical Phenotyping of NHS General Adult Psychiatry (GAP) Inpatients | 2026-12-31 |
| NCT06957808King's College LondonInvestigating the Effect of Diroximel Fumarate on Glutathione in Schizophrenia | 2027-01-20 |
| NCT03194815University of CambridgeIVIG and Rituximab in Antibody-associated Psychosis - SINAPPS2 | 2027-04-30 |
| NCT05905003Brigham and Women's HospitalAMP SCZ® Observational Study: PREDICT-DPACC | 2027-04-30 |
Add all 6 to your calendar (.ics) → With an account.
Among the 75 studies in Psychotic Disorders with a site in United Kingdom, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This clinical trial will evaluate the effectiveness and cost-effectiveness of a link work intervention for supporting people with severe mental health difficulties to attend a routine dental appointment. There are two main outcomes, namely: i) attendance at a routine dental appointment; and ii) oral health quality of life.
The main predictions are that:
Aim: To evaluate the effectiveness and cost-effectiveness of a link work intervention to facilitate dental attendance in people with severe mental illness.
Methods: An effectiveness randomised-controlled trial with integrated cost-effectiveness analysis and process evaluation. 480 participants will be recruited from five NHS Trusts and randomised (ratio 1:1) to either treatment as usual or treatment as usual plus the link work intervention. The link work intervention will follow the manual co-developed and used in the feasibility trial. Blind research assistants will support participants to complete assessments at baseline and after nine-months. The investigators will obtain consent to access participant's dental visiting data via the Business Services Authority. The primary outcomes are i) attendance at a routine dental appointment, and ii) oral health related quality of life. Health economics analysis will assess whether the intervention is cost-effective. A qualitative process evaluation will help to understand how it works and might be implemented.
Results/conclusions: This research hopes to produce the first evidenced-based intervention for improving the oral health of people with severe mental illness. It could help to overcome inequities in dental access.
1,593 studies on the registry are indexed under Psychotic Disorders; 283 are open to participants now.
This study's planned enrollment of 480 is above the median of 65 across 1,326 interventional studies indexed under Psychotic Disorders.
Browse Psychotic Disorders studies →This is the only study on the registry with Lancashire and South Cumbria NHS Foundation Trust as lead sponsor.
Compared within Psychotic Disorders, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Psychological Well-Being. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Treatment as usual will include any treatments or services that the participant would normally have access to outside of the trial. For people with severe mental illness this may include support from a care coordinator, support worker, psychologist, occupational therapist, and/or psychiatrist for care around their mental health. Treatment as usual may include medication and case management. The investigators will monitor, rather than withhold, assessment and treatment for oral health in the treatment as usual arm.
Participants in this arm will receive treatment as usual plus the link work intervention. This will consist of six sessions with a link worker over nine-months who will offer practical and emotional support around accessing a routine dental appointment.
Behavioral: Link work intervention
The mental health link work intervention uses link workers to empower and assist people with severe mental illness currently supported by secondary care mental health services, but not dental services, to access planned dental appointments. The link work intervention in the study proposal has the following dimensions: * Delivered by mental health support workers. * Focused on oral health as the primary health issue. * Setting is in secondary mental health care linking to dental care * Primary role is navigating or bridging services. * It builds motivation where needed and offers advocacy. * Its builds self-efficacy and recursively through social persuasion, positive reinforcement, and positive experiences of dental visits and interacting with dental services. * Training and supervision to link workers supports intervention delivery.
Attendance at a planned care appointments
As measured by the National Health Services Business Services Authority (NHS BSA).
Time frame: From baseline to nine-month follow-up assessment.
Oral health related quality of life
Oral Health Impact Profile - 14 item version (OHIP-14), range: 0-56, higher scores indicate worse oral health related quality of life
Time frame: From baseline to nine-month follow-up assessment .
Self-reported attendance at a planned dental appointment.
Self-report dental attendance items.
Time frame: From baseline to nine-month follow-up assessment.
Orofacial pain & disability
Manchester Orofacial Pain Disability Scale. Two binary outcomes plus scale. Range: 0-52. Higher scores indicates greater pain (binary) / help seeking (binary) / pain related disability (scale).
Time frame: From baseline to nine-month follow-up assessment
Confidence around dental visiting
Single item of self-efficacy around attendance. Range 1-7. A higher score indicates greater confidence around dental visiting.
Time frame: From baseline to nine-month follow-up assessment.
Self-esteem
Rosenberg Self-Esteem Scale. Range: 0-30. A higher score indicates better self-esteem.
Time frame: From baseline to nine-month follow-up assessment
Dental anxiety
Modified Dental Anxiety Scale. Range: 5-25. A higher score indicates greater levels of dental anxiety.
Time frame: From baseline to nine-month follow-up assessment.
General anxiety
Generalised Anxiety Disorder Questionnaire. Range: 0-21. A higher score indicates greater levels of anxiety.
Time frame: From baseline to nine-month follow-up assessment .
Depression
Patient Health Questionnaire - 9 items. Range 0-27. A higher score indicates greater levels of depression.
Time frame: From baseline to nine-month follow-up assessment.
The number of planned dental appointments attended
Recorded via the National Health Service Business Services Authority.
Time frame: From baseline to nine-month follow-up assessment.
Self-reported access to free/subsidised dental care.
Self-report items
Time frame: From baseline to nine-month follow-up assessment.
Exemption status for dental care
As recorded by the National Health Service Business Services Authority
Time frame: From baseline to nine-month follow-up assessment.
Completion of a course of dental treatment
As record via the National Health Service Business Services Authority.
Time frame: From baseline to nine-month follow-up assessment.
Self-reported utilisation of urgent or emergency dental services.
Self-report items
Time frame: From baseline to nine-month follow-up assessment.
Quality adjusted life years
European Quality of Life five-dimensional questionnaire (EQ-5D-5L). Five health dimensions plus overall health score on a visual analogue scale range. Range on visual analogue scale: 0-100. A higher score indicates better health.
Time frame: From baseline to nine-month follow-up assessment.
Utilization of healthcare resources
Co-designed health economics questionnaire recording utilisation of services and treatment.
Time frame: From baseline to nine-month follow-up
Plan to share: Yes — Following publication of the trial results, the investigators will make suitable arrangements for anonymised data to be available from the research team, in line with NIHR data sharing guidance. This will be outlined in the Data Access Management Plan (DAMP) developed in the early phases of the project.
Supporting information: Study protocol, Statistical analysis plan
Time frame: Exact plans and timescales will be developed during the early phases of the project and outlined within a Data Access Management Plan (DAMP). The IPD will only be available from the point of the results being published and after 31/07/2029.
Access criteria: Exact specifications around who can apply for access to anonymized data and how will be outlined in the Data Access Management Plan (DAMP). Key considerations will include the confidentiality and privacy of participants; respect to the terms of consent by individuals who are involved in research; consistency with relevant legal, ethical and regulatory frameworks; and guarding against unreasonable costs.
No publications or documents are linked to this record.
Started May 2026 (actual). Primary completion is estimated for Jul 2029, 38 months after the start.
Of 460 non-industry interventional studies with no phase under Psychotic Disorders, half reached primary completion within 34 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 52. This study's planned 38 months is above that.
Counting every sponsor, half of 462 studies reached it within 34 months; a quarter within 19 and three quarters within 52.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.